Publications by authors named "Camille Mane"

Claim this Profile
C
Ceftobiprole in Critically Ill Patients: Proposal for New Dosage Regimens.
Sarah Baklouti, Camille Mané, Youssef Bennis, Charles-Edouard Luyt, Cédric Joseph

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection.
Patrick Seraissol, Thomas Lanot, Sarah Baklouti, Camille Mané, Stéphanie Ruiz

J Pharm Biomed Anal· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data.
Cyril Leven, Anne Coste, Camille Mané

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study.
Camille Mané, Clément Delmas, Jean Porterie, Géraldine Jourdan, Patrick Verwaerde

J Transl Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients.
Sarah Baklouti, Clémence Massip, Camille Mane, Hélène Guet-Revillet, Marlène Murris

J Antimicrob Chemother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis